About SeraNovo

SeraNovo is a privately held, Netherlands-based pharmaceutical formulation company focused on solving the bioavailability problem. Our formulation platform harnesses biocompatible eutectic solvents to enable efficient absorption of poorly soluble active pharmaceutical ingredients. Supported by a comprehensive pending intellectual property portfolio, SeraNovo’s mission is to enable new oral medical cures to reach patients.

Meet the Leadership Team

Our Team consists of a combination of highly motivated founders with a skilled R&D team, backed by several experienced and professional advisors.

Niall Hodgins
Niall HodginsCo-Founder and CEO
With a scientific background, Niall is the technology co-inventor and SeraNovo’s CEO
Bastiaan Kluft
Bastiaan KluftCo-Founder and CSO
Passionate about cutting edge science, co-inventor Bastiaan is SeraNovo’s CSO.
Joost Holthuis
Joost HolthuisStrategic Advisor
Having extensive experience in the formulation industry, Joost provides SeraNovo with weekly advice on matters of strategy.
Erik Frijlink
Erik FrijlinkScientific Advisor
As Professor of Pharmaceutical Technology of the University of Groningen, Erik offers valuable scientific advice.
Martin Bakker
Martin BakkerDirector of Business Development
With significant sales experience in the pharmaceutical formulation industry, Martin leads our business development team.